Dr Sabharwal's Manufacturing Labs Ltd
Dr. Sabharwals Manufacturing Labs Limited is engaged in manufacturing, supply and distribution of surgical equipments such as P.O.P and adhesive tapes.
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE 10.7 %
- ROE 6.20 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 27.8%
Cons
- The company has delivered a poor sales growth of 9.76% over past five years.
- Company has a low return on equity of 7.78% over last 3 years.
- Debtor days have increased from 70.2 to 118 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|
4.29 | 4.12 | 3.78 | 3.93 | 4.09 | 4.23 | 5.60 | 5.69 | 6.26 | 6.67 | |
4.08 | 3.90 | 3.96 | 4.26 | 4.07 | 4.25 | 5.33 | 5.07 | 5.86 | 6.54 | |
Operating Profit | 0.21 | 0.22 | -0.18 | -0.33 | 0.02 | -0.02 | 0.27 | 0.62 | 0.40 | 0.13 |
OPM % | 4.90% | 5.34% | -4.76% | -8.40% | 0.49% | -0.47% | 4.82% | 10.90% | 6.39% | 1.95% |
0.29 | 0.12 | 0.16 | 1.00 | 0.20 | 0.23 | 0.24 | 0.24 | 0.28 | 1.16 | |
Interest | 0.11 | 0.10 | 0.14 | 0.14 | 0.07 | 0.00 | 0.04 | 0.05 | 0.01 | 0.00 |
Depreciation | 0.12 | 0.11 | 0.11 | 0.10 | 0.10 | 0.10 | 0.09 | 0.09 | 0.18 | 0.22 |
Profit before tax | 0.27 | 0.13 | -0.27 | 0.43 | 0.05 | 0.11 | 0.38 | 0.72 | 0.49 | 1.07 |
Tax % | 33.33% | 15.38% | -29.63% | 16.28% | 20.00% | -18.18% | 34.21% | 33.33% | 40.82% | |
0.18 | 0.11 | -0.19 | 0.36 | 0.04 | 0.13 | 0.26 | 0.48 | 0.29 | 0.80 | |
EPS in Rs | ||||||||||
Dividend Payout % | 66.67% | 72.73% | 0.00% | 0.00% | 0.00% | 0.00% | 30.77% | 25.00% | 27.59% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 10% |
3 Years: | 14% |
TTM: | -28% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 71% |
3 Years: | 31% |
TTM: | -37% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 6% |
3 Years: | 8% |
Last Year: | 6% |
Balance Sheet
Figures in Rs. Crores
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | |
---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 | 0.80 |
Reserves | 2.93 | 2.94 | 2.75 | 3.11 | 3.15 | 3.28 | 3.44 | 3.78 | 3.97 |
0.35 | 0.94 | 0.68 | 0.70 | 0.33 | 0.00 | 0.00 | 0.00 | 0.00 | |
1.04 | 1.03 | 0.91 | 0.85 | 1.08 | 0.86 | 0.77 | 1.39 | 4.16 | |
Total Liabilities | 5.12 | 5.71 | 5.14 | 5.46 | 5.36 | 4.94 | 5.01 | 5.97 | 8.93 |
1.36 | 1.23 | 1.13 | 0.99 | 0.95 | 0.91 | 0.90 | 0.82 | 5.13 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
3.76 | 4.48 | 4.01 | 4.47 | 4.41 | 4.03 | 4.11 | 5.15 | 3.80 | |
Total Assets | 5.12 | 5.71 | 5.14 | 5.46 | 5.36 | 4.94 | 5.01 | 5.97 | 8.93 |
Cash Flows
Figures in Rs. Crores
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | |
---|---|---|---|---|---|---|---|---|---|
0.85 | -0.08 | -0.01 | -0.12 | 0.91 | 0.19 | 2.05 | 0.47 | 1.97 | |
-0.13 | -0.01 | 0.00 | 0.03 | 0.00 | -0.06 | -0.08 | -0.01 | -4.49 | |
-0.66 | 0.45 | -0.26 | 0.01 | -0.37 | -0.33 | 0.00 | -0.09 | -0.14 | |
Net Cash Flow | 0.06 | 0.36 | -0.27 | -0.08 | 0.54 | -0.20 | 1.97 | 0.37 | -2.66 |
Ratios
Figures in Rs. Crores
Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | |
---|---|---|---|---|---|---|---|---|---|
Debtor Days | 74.87 | 101.88 | 72.42 | 74.30 | 91.03 | 67.30 | 29.98 | 62.86 | 117.78 |
Inventory Days | 185.65 | 260.71 | 248.79 | 203.83 | 98.58 | 77.11 | 63.98 | 71.03 | 83.53 |
Days Payable | 45.62 | 89.62 | 98.21 | 88.48 | 101.24 | 57.83 | 24.12 | 45.90 | 289.64 |
Cash Conversion Cycle | 214.89 | 272.97 | 223.00 | 189.65 | 88.36 | 86.58 | 69.84 | 88.00 | -88.33 |
Working Capital Days | 224.62 | 263.12 | 271.34 | 322.28 | 235.60 | 224.35 | 41.71 | 58.37 | -22.74 |
ROCE % | 5.71% | -2.92% | 3.85% | 2.70% | 2.63% | 10.10% | 17.46% | 10.70% |
Documents
Announcements
- Shareholding for the Period Ended March 31, 2017 24 Apr 2017
- Shareholding for the Period Ended December 31, 2016 24 Apr 2017
- Shareholding for the Period Ended September 30, 2016 27 Oct 2016
- Shareholding for the Period Ended March 31, 2016 11 Aug 2016
- Standalone Financial Results for June 30, 2016 2 Aug 2016
Annual reports
No data available.